Dr. Rakkhit is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
925 Gessner Rd
Ste 200
Houston, TX 77024Phone+1 713-827-9525Fax+1 713-468-3561
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2006 - 2009
Baylor College of MedicineResidency, Internal Medicine, 2003 - 2006
Medical University of South CarolinaClass of 2003
Certifications & Licensure
TX State Medical License 2006 - 2026- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Publications & Presentations
PubMed
- 332 citationsHigh risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller.Ana M. Gonzalez-Angulo, Jennifer K. Litton, Kristine Broglio, Funda Meric-Bernstam, Ronjay Rakkhit
Journal of Clinical Oncology. 2009-12-01
Authored Content
- BCR-JAK2 fusion as a result of a translocation (9;22)(p24;q11.2) in a patient with CML-like myeloproliferative diseaseJanuary 2012
- High risk of recurrence for patients with Her2 positive breast cancers 1 cm or smallerDecember 2009
Press Mentions
New Legal Risk for Oncologists? Stark Law Fears Loom Ahead of DeadlineMay 8th, 2023
Other Languages
- Spanish, Bengali
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
